Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Apple? Just a Bite, Please: ETF Alternatives for Hot Stock Picks

By Will Ashworth, InvestorPlace Contributor

This week, we look at bundling recent InvestorPlace stock picks such as Apple and Comcast into exchange-traded funds.

Domtar Dives Further Into the Diaper Biz

By Will Ashworth, InvestorPlace Contributor

Domtar is paying $272 million to enter the private-label infant diaper business, making it a player in the North American market and a more attractive investment.

Should I Buy Accenture? 3 Pros, 3 Cons

By Will Ashworth, InvestorPlace Contributor

Accenture cut its revenue guidance for the fourth quarter, sending its stock for a tumble. But was that spill just an opportunity for dip-buyers?

Western Digital vs. Seagate Technology: Which Is Better?

By Will Ashworth, InvestorPlace Contributor

The hard-disk drive manufacturers' stocks are on fire these days, but which is the better stock? And can they keep it going?

Middleby’s Shareholders Have Lost Their Marbles

By Will Ashworth, InvestorPlace Contributor

Middleby's shareholders voted down CEO Selim Bassoul's 2013 compensation package -- a bad move, considering he's one of the best-performing CEOs out there.

3 Share Repurchase Superstars to Watch

By Will Ashworth, InvestorPlace Contributor

It can be hard to execute share buybacks properly but, as Factset's Buyback Quarterly shows, these three S&P 500 companies have sure made it look easy.

3 Ways to Trade Diabetes Treatment

By Will Ashworth, InvestorPlace Contributor

The treatment of diabetes continues to be a huge boon to drug companies. Here is a look att three potential stock picks for the space.

Get a Taste of Smucker: ETF Alternatives for Hot Stock Picks

By Will Ashworth, InvestorPlace Contributor

This week, we look at ways to get exposure to companies like J.M. Smucker, Daimler and other InvestorPlace stock picks via quality exchange-traded funds.

3 Stock Splits You Can Count On

By Will Ashworth, InvestorPlace Contributor

If you believe the empirical evidence that suggests investing in stock splits works, you might want to consider these three splitters.

Stock Showdown: DirecTV vs. Dish Network

By Will Ashworth, InvestorPlace Contributor

DirecTV's rumored buy of Hulu appears to widen the gap between it and fellow satellite player Dish Network. But is it the better stock?

Load More